This is not the most recent version of the article. View current version (28 JUL 2014)

Intervention Protocol

You have free access to this content

Antimetabolites for preventing trabeculectomy failure in people undergoing cataract surgery

  1. Roger E Thomas1,*,
  2. Andrew Crichton2,
  3. Bennett C Thomas3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 28 JUN 2013

DOI: 10.1002/14651858.CD010627


How to Cite

Thomas RE, Crichton A, Thomas BC. Antimetabolites for preventing trabeculectomy failure in people undergoing cataract surgery (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010627. DOI: 10.1002/14651858.CD010627.

Author Information

  1. 1

    University of Calgary, Department of Family Medicine, Faculty of Medicine, Calgary, Alberta, Canada

  2. 2

    University of Calgary Medical School, Ophthalmology, Department of Surgery, Calgary, Alberta, Canada

  3. 3

    Calgary, Alberta, Canada

*Roger E Thomas, Department of Family Medicine, Faculty of Medicine, University of Calgary, UCMC, #1707-1632 14th Avenue, Calgary, Alberta, T2M 1N7, Canada. rthomas@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 28 JUN 2013

SEARCH

This is not the most recent version of the article. View current version (28 JUL 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To identify all randomised controlled trials (RCTs) of antimetabolites during or after cataract surgery to prevent the failure of an earlier trabeculectomy resulting from the later cataract surgery.